The message is clear: Moderna is trying to outdo Pfizer
Moderna says Pfizer is trying to fathom how to play its game, while Pfizer says it’s proud of every shot-maker’s efforts
Pfizer has been first across the finish line in nearly every leg of the Covid-19 vaccine race, but Moderna executives say their company’s long experience with messenger RNA (mRNA) technology gives it a more enduring advantage.
“We’re not dabbling” in mRNA, the technology that is the backbone of both the leading US vaccines, Moderna president Stephen Hoge said. “We’ve been doing this for a few years; we’re the creators of this space.”
Hoge said Pfizer’s experience with fast clinical trials and mass production allowed it to excel in the short run. The pharmaceutical giant, founded in 1849, has developed countless household-name therapies. Additionally, its partner, BioNTech, has been working on mRNA for years...